# BC Cancer Agency

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/bc-cancer-agency/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 63.3 |
| Citations | 4,535,830 |
| City | Vancouver |
| Country | CA |
| Description | BC Cancer Agency is a research organisation in Vancouver, CA. OpenAlex records 17,005 works and 4,535,830 citations for it. 2,553 researchers list it as their most recent affiliation. |
| Homepage | http://www.bccancer.bc.ca/ |
| OpenAlex ID | https://openalex.org/I1289530486 |
| Region | British Columbia |
| Researchers | 2,553 |
| ROR ID | https://ror.org/03sfybe47 |
| Type | healthcare |
| Works | 17,005 |

## University papers

Showing 12 of 130.

- [Signatures of mutational processes in human cancer](https://scholariq.org/papers/signatures-of-mutational-processes-in-human-cancer/)
- [The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups](https://scholariq.org/papers/the-genomic-and-transcriptomic-architecture-of-2-000-breast-tumours-reveals/)
- [Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries](https://scholariq.org/papers/global-surveillance-of-trends-in-cancer-survival-2000-14-concord-3-analysis-of/)
- [Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma](https://scholariq.org/papers/nivolumab-versus-everolimus-in-advanced-renal-cell-carcinoma/)
- [Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer](https://scholariq.org/papers/docetaxel-plus-prednisone-or-mitoxantrone-plus-prednisone-for-advanced-prostate/)
- [Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast Cancer](https://scholariq.org/papers/trastuzumab-after-adjuvant-chemotherapy-in-her2-positive-breast-cancer/)
- [Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma](https://scholariq.org/papers/nivolumab-plus-ipilimumab-versus-sunitinib-in-advanced-renal-cell-carcinoma/)
- [Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy](https://scholariq.org/papers/increased-survival-with-enzalutamide-in-prostate-cancer-after-chemotherapy/)
- [Abiraterone and Increased Survival in Metastatic Prostate Cancer](https://scholariq.org/papers/abiraterone-and-increased-survival-in-metastatic-prostate-cancer/)
- [The repertoire of mutational signatures in human cancer](https://scholariq.org/papers/the-repertoire-of-mutational-signatures-in-human-cancer/)
- [Pan-cancer analysis of whole genomes](https://scholariq.org/papers/pan-cancer-analysis-of-whole-genomes/)
- [Rheumatoid arthritis](https://scholariq.org/papers/rheumatoid-arthritis/)

## University researchers

- [Kim N.](https://scholariq.org/researchers/kim-n/)
- [Caroline Lohrisch](https://scholariq.org/researchers/caroline-lohrisch/)
- [Mohammad Atiquzzaman](https://scholariq.org/researchers/mohammad-atiquzzaman/)
- [Jonathan Avery](https://scholariq.org/researchers/jonathan-avery/)
- [Dilshani Induruwage](https://scholariq.org/researchers/dilshani-induruwage/)
- [Malak Ghaddar](https://scholariq.org/researchers/malak-ghaddar/)

## University top topics

Showing 8 of 25.

- [Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/lymphoma-diagnosis-and-treatment/)
- [Prostate Cancer Treatment and Research](https://scholariq.org/topics/prostate-cancer-treatment-and-research/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Advanced Radiotherapy Techniques](https://scholariq.org/topics/advanced-radiotherapy-techniques/)
- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Prostate Cancer Diagnosis and Treatment](https://scholariq.org/topics/prostate-cancer-diagnosis-and-treatment/)
- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.